Delinking compensation from list prices could slash U.S. drug costs by nearly $100 billion (IMAGE)

University of Southern California

Delinking compensation from list prices could slash U.S. drug costs by nearly $100 billion

Caption

Net drug spending vs. scenario with fixed intermediary fees

Credit

USC Schaeffer Center

Usage Restrictions

Must credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.